TPT Global Tech Inc. (OTCMKTS:TPTW) Stock Falls After The Recent News: Now What?

September 20, 2021

TPT Global Tech Inc. (OTCMKTS:TPTW) fell 20%. The company’s Board of Directors amended TPT Global’s Certificate of Incorporation regarding the involuntary and voluntary conversion of Series D Preferred Stock features as per the provisions of the certificate of incorporation and the company’s by-laws. The amended features include 6% Cumulative Annual Dividends payable on the acquisition value ion common stock or cash at the Board’s discretion. The automatic Series D Preferred…

Read More >>

BioPower Operations Corporation (OTCMKTS:BOPO) Stock Falls On Profit Taking: Now What?

September 20, 2021

The BioPower Operations Corporation (OTCMKTS:BOPO) stock has had a bit of a rollercoaster ride in recent days. This past Friday the stock endured a strong correction and went down by as much as 38%. While it is true that the BioPower stock has recorded considerable gains in recent months, the latest correction did not seem to be a case of profit booking. In addition to that, it should be noted…

Read More >>

Cybernetic Technologies Ltd (OTCMKTS:HPIL) Stock Sees Buying Interest At Lower Level

September 17, 2021

There are times when stocks end up clocking significant gains despite there being no news about the companies in question and such a thing happened with the Cybernetic Technologies Ltd (OTCMKTS:HPIL) stock on Thursday. There has been no news about the company for more than a month but the stock managed to attract the attention of investors in a big way on Thursday. The HPIL stock ended the day with…

Read More >>

HUMBL Inc (OTCMKTS:HMBL) Stock Is Unable To Sustain at Higher Level: But Why?

September 17, 2021

At the beginning of the year, the HUMBL Inc (OTCMKTS:HMBL) stock was one of the hottest stocks in the penny stock space and managed to clock considerable gains amidst heavy interest. However, things have been far more sober in the past months. Yesterday, the stock was in focus among investors following a key announcement from the company and clocked gains of 4%. That being said, it should also be noted…

Read More >>

Tuesday Morning (NASDAQ:TUEM) Stock Bounces back Strongly: Now What?

September 17, 2021

Well known off-price retailer of home decor and home goods Tuesday Morning (NASDAQ:TUEM) saw its stock make a strong recovery on Friday after having declined recently. The stock went up by as much as 28% and emerged as one that could be watched closely today. Yesterday, the stock was in focus after the company announced that it appointed a new Principal and Chief Merchant in the form of Paul Metcalf….

Read More >>

Leap Therapeutics Inc (NASDAQ:LPTX) Stock Continues to Attract Buyers: But Why?

September 16, 2021

In the past week, the Leap Therapeutics Inc (NASDAQ:LPTX) stock has emerged as one of the stronger performers and the trend continued on Wednesday. Yesterday, the Leap Therapeutics stock ended the day with gains of 8% and that took its cumulative gains for the past week to as much as 24%. There was no news about the company yesterday but earlier on in the week Leap Therapeutics announced that it…

Read More >>

SunHydrogen Inc (OTCMKTS:HYSR) Stock Continues to Consolidate After The Recent Move

September 16, 2021

SunHydrogen Inc (OTCMKTS:HYSR) is a company that came up with an innovative piece of tech that uses water and sunlight to create renewable hydrogen. It recently announced that it was extending the sponsored research agreement it has with the University of Iowa. The renewed commitment with the university will allow SunHydrogen to continue with its work of trying to develop its green nanoparticle-based hydrogen tech and manufacture it on a…

Read More >>

CytoDyn Inc (OTCMKTS:CYDY) Administers Leronlimab Drug to First Patient in Major Phase 3 Covid-19 Trial

September 15, 2021

CytoDyn Inc (OTCMKTS:CYDY) has made a statement regarding its treatment of the first patient with its much-touted about drug candidate leronlimab (Vyrologix or PRO 140), in a crucial Phase 3 Covid-19 trial in Brazil. The treatment is for patients with severe symptoms. After the enrolment of 245 patients (40% of the total number in the trial), an interim analysis will be conducted after 28 days. The trial is being conducted…

Read More >>

Maison Luxe Inc (MASN) Stock Turns Volatile On High Volume

September 15, 2021

In the past week, the Maison Luxe Inc (OTCMKTS:MASN) stock has come into attention among investors in a big way and the situation remained the same on Tuesday. Yesterday, the stock jumped by 11% amidst continued interest and that took its gains over the course of the past week to as much as 22%. The company is a leading worldwide operators in the luxury goods space and back on August…

Read More >>

Leap Therapeutics Inc (LPTX) Stock Sees Value Buying After The News

September 14, 2021

Leap Therapeutics Inc (NASDAQ:LPTX) stock soared 21% on Monday. This rise comes after the company announced that it would present initial results from theDisTinGuish study. The study is a Phase IIa clinical trial for DKN-01, the company’s (DKK1) antibody used with tislelizumab and chemotherapy to treat patients with gastroesophageal junction or gastric cancer. The company has found that DKN-01, when combined with chemotherapy andtislelizumab as the first-line drug for gastroesophageal…

Read More >>